Jones Financial Companies
RLYB icon

Jones Financial Companies’s Rallybio RLYB Stock Holding History

Jones Financial Companies’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11
Closed -$50 – 4572
2025
Q3 		$50 Buy
+11
New +$46 ﹤0.01% 4183

Other funds holding RLYB

AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jones Financial Companies's RLYB Position: Q4 2025 in Review

Jones Financial Companies sold out of Rallybio (RLYB) in Q4 2025, closing a stake of 11 shares — an estimated $50 sold.

Jones Financial Companies first reported a position in RLYB in Q3 2025 and held it in 1 quarter. The position peaked at $50 in Q3 2025. 46 funds tracked by Wall St. Rank hold RLYB as of Q4 2025.

  • Jones Financial Companies reported no remaining Rallybio position as of Q4 2025 after selling out during the quarter.
  • Jones Financial Companies sold 11 Rallybio shares in Q4 2025, an estimated $50.
  • Jones Financial Companies first reported a position in Rallybio in Q3 2025 and held it in 1 quarter.
  • Jones Financial Companies's Rallybio position peaked at $50 in Q3 2025.
  • 46 funds tracked by Wall St. Rank held Rallybio as of Q4 2025.

Based on Jones Financial Companies's 13F filing for Q4 2025, filed 17 Feb 2026.